Symbiotec Pharmalab Limited is a research-driven pharmaceutical and biotechnology company engaged in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company has a strong presence in corticosteroid and steroidal-hormone APIs, along with capabilities in biotechnology, fermentation and complex injectables.
The company operates an integrated manufacturing platform and serves pharmaceutical customers across international markets. Its business is supported by research and development capabilities, manufacturing infrastructure and regulatory approvals for global markets.
Key Highlights
- 🧪 Corticosteroid & Steroidal-Hormone APIs
- 🔬 Research-Driven Pharmaceutical & Biotechnology Business
- ⚙️ Chemical Synthesis & Fermentation Capabilities
- 💉 Complex Injectable Development & Manufacturing
- 🌍 Global Customer & International Market Presence
Disclaimer
This article is for informational and educational purposes only and should not be construed as investment advice or a recommendation.
Symbiotec Pharmalab IPO Timetable
| Particular | Date |
| IPO Open Date | 24 August 2026 |
| IPO Close Date | 27 August 2026 |
| Allotment Date | 31 August 2026 |
| IPO Listing Date | 01 September 2026 |
Symbiotec Pharmalab IPO Details
| Issue Type | Bookbuilding IPO |
| Face Value | Rs. 2 Per Equity Share |
| IPO Price | Rs. 938 to 988 Per Equity Share |
| Market Lot | 15 Share |
| ISIN Code | INE899I01028 |
| Listing At | BSE,NSE |
| Issue Size | Rs. 1757 Crore. |
Symbiotec Pharmalab IPO Lot Size
| Application | Lots | Shares | Amount |
| Minimum | 1 | 15 | Rs. 14,820 |
| Maximum | 13 | 195 | Rs. 192,660 |
| Small HNI (Minimum) | 14 | 210 | Rs. 207,480 |
| Big HNI (Minimum) | 68 | 1020 | Rs. 1,007,760 |
Symbiotec Pharmalab IPO Allotment Status
Click Here To Check IPO Allotment Status Symbiotec Pharmalab IPO
Click Here To Get ASBA Forms Symbiotec Pharmalab IPO
Company Financials :
| Particular | Latest Year | Prior Year | 2 Years Prior |
| Total Assets | 1780.79 | 1579.65 | 1294.79 |
| Total Revenue | 872.26 | 755.98 | 723.33 |
| Profit After Tax | 109.90 | 96.79 | 100.06 |
Company Promoters:
Anil Satwani, Kashish Satwani, Sushil Satwani and Satwani Holdings LLP.
Registrar & Company Details
| Company Contact Information | IPO Registrar |
| Symbiotec Pharmalab Ltd. 385/2, Pigdamber, Rau, Mhow, Indore, Madhya Pradesh, 453331 Contact: 7316676405 Email: secretarial@symbiotec.com Web: https://www.symbiotec.com/ | MUFG Intime India Private Limited Contact:- +91 810 811 4949 Email:- symbiotecpharmalab.ipo@in.mpms.mufg.com Web:- https://in.mpms.mufg.com/ |
Risk Disclosure :- Investing in Initial Public Offerings (IPOs) involves significant market risks. The information provided in this blog post is for educational and informational purposes only and should not be treated as investment advice or a recommendation to subscribe to any IPO. Investors must carefully read the Red Herring Prospectus (RHP), company financials, and all risk factors before investing.
IPO allotment is not guaranteed, and the listing price may differ from expectations due to market demand, business fundamentals, and overall market conditions. Newly listed companies may experience high volatility in the initial days of trading. Past performance of other IPOs does not indicate or assure future results.
Investors should evaluate their risk appetite, financial objectives, and seek independent professional advice before making any investment decisions.
